AKCEA THERAPEUTICS, INC. - FORM 10-K - EX-23.1 - March 2, 2020

Attached files

file filename
EX-32.1 - EX-32.1 - AKCEA THERAPEUTICS, INC.akca-ex321_10.htm
EX-31.2 - EX-31.2 - AKCEA THERAPEUTICS, INC.akca-ex312_9.htm
EX-31.1 - EX-31.1 - AKCEA THERAPEUTICS, INC.akca-ex311_8.htm
EX-21.1 - EX-21.1 - AKCEA THERAPEUTICS, INC.akca-ex211_7.htm
EX-10.15 - EX-10.15 - AKCEA THERAPEUTICS, INC.akca-ex1015_357.htm
EX-10.4 - EX-10.4 - AKCEA THERAPEUTICS, INC.akca-ex104_278.htm
EX-4.5 - EX-4.5 - AKCEA THERAPEUTICS, INC.akca-ex45_490.htm
10-K - 10-K - AKCEA THERAPEUTICS, INC.akca-10k_20191231.htm

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the incorporation by reference in the following Registration Statements:

 

 

(1)

Registration statement (Form S-3ASR No. 333-227403) pertaining to Akcea Therapeutics, Inc.’s shelf registration statement for common stock, preferred stock, debt securities, warrants or any combination of the foregoing;

 

(2)

Registration Statement (Form S-8 No. 333-231613) pertaining to the 2017 Employee Stock Purchase Plan of Akcea Therapeutics, Inc.,

 

(3)

Registration Statement (Form S-8 No. 333-228969) pertaining to the 2015 Equity Incentive Plan of Akcea Therapeutics, Inc.,

 

(4)

Registration Statement (Form S-8 No. 333-225730) pertaining to the 2015 Equity Incentive Plan and 2017 Employee Stock Purchase Plan of Akcea Therapeutics, Inc., and

 

(5)

Registration Statement (Form S-8 No. 333-219290) pertaining to the 2015 Equity Incentive Plan and 2017 Employee Stock Purchase Plan of Akcea Therapeutics, Inc;

 

of our report dated March 2, 2020, with respect to the consolidated financial statements of Akcea Therapeutics, Inc., included in this Annual Report (Form 10-K) of Akcea Therapeutics, Inc. for the year ended December 31, 2019.

 

 

/s/ Ernst & Young LLP

 

 

San Diego, California

March 2, 2020

 

AKCEA THERAPEUTICS, INC. Reports